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The T-box transcription factor Tbx1 is required for inner ear morphogenesis. Tbx1 null mutants have a small otocyst that fails to grow and remodel
and does not give rise to the vestibular and cochlear apparata. Here we show that Tbx1 expression-driven cell tracing identifies a population of otic
epithelial cells that contributes to most of the otocyst. Tbx1 is essential for the contribution of this population to the inner ear. Ablation of Tbx1 after
this cell population has established itself in the otocyst, restores marker expression lost in germ line mutants, but causes severe reduction in mitotic
activity, cell autonomously. Furthermore, timed cell fate mapping demonstrates that loss of Tbx1 switches the fate of some members of the Tbx1-
dependent cell population, from non-neurogenic to neurogenic, an event associated with activation of the Delta–Notch pathway. Finally, tissue-
specific ablation of Tbx1 demonstrates that, while the abovementioned phenotypic abnormalities are due to loss of epithelial expression of Tbx1,
cochlear morphogenesis requires mesodermal Tbx1 expression. We conclude that the main functions of Tbx1 in the inner ear are to control, cell-
autonomously, contribution, size and fate of a large population of otic epithelial cells, and, cell non-autonomously, cochlear morphogenesis.
© 2006 Elsevier Inc. All rights reserved.Keywords: Tbx1; Inner ear; Neurogenesis; Cell fate specification; Dll1; Notch1; Ngn1; Periotic mesenchyme; Otic epitheliumIntroduction
The inner ear derives from the otic placode, initially
recognized as a thickened ectodermal patch near the hindbrain
at embryonic day (E) 8 in mice (Radde-Gallwitz et al., 2004).
The otic placode undergoes invagination and becomes the otic
pit, which in turn enlarges and closes off from the ectoderm to
form the otocyst by E9.5 (Barald and Kelley, 2004). Cells in the
otocyst undergo a series of cell fate specification events and
differentiate into the various types of cells that populate the
inner ear structures (Fekete and Wu, 2002). From E9.5 to E12,⁎ Corresponding author. Institute of Biosciences and Technologies, Texas
A&M University System, 2121 W. Holcombe, Room 820C, TX, USA. Fax: +1
713 677 7689.
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doi:10.1016/j.ydbio.2006.10.002neuronal precursors delaminate from a specific region of the
otic epithelium, the neurogenic region, to contribute to the
cochleo-vestibular ganglion (CVG). The neurogenic region is
defined by expression of proneural genes encoding bHLH
transcription factors, including Neurogenin 1 (Ngn1) and
NeuroD (Kim et al., 2001; Liu et al., 2000; Ma et al., 1998).
By E12, the delamination process is complete, and the otocyst
exhibits recognizable primordial structures of the sensory
organs and endolymphatic duct (Barald and Kelley, 2004).
Tbx1 is a member of the gene family encoding transcription
factors with a conserved DNA-binding T-box domain. Hap-
loinsufficiency of TBX1 has been associated with DiGeorge
syndrome (DGS), a disorder mostly caused by a segmental
deletion of chromosome 22q11.2 (del22q11.2). Del22q11.2
includes TBX1, and patients with mutation of this gene present
with a phenotype similar to DGS, including the ear phenotype
(Yagi et al., 2003). Most DGS patients have hearing impairment,
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al., 1999; Swillen et al., 1999).
During otocyst development, Tbx1 is expressed in a
subregion of the otic epithelium and in the periotic mesenchyme
(Raft et al., 2004; Vitelli et al., 2003). In Tbx−/− animals, the
otocyst is small and the sensory organs do not form (Moraes et
al., 2005; Raft et al., 2004; Vitelli et al., 2003). In addition, the
neurogenic region of the otic epithelium is expanded (Raft et al.,
2004), and the endolymphatic duct appears to be enlarged
(Moraes et al., 2005). Based on the morphogenetic defects,
affected gene expression patterns and chimeric analysis, Vitelli
et al. suggested that Tbx1 is required for expansion of a
subpopulation of otic epithelia cells (Vitelli et al., 2003). Raft et
al. speculated that Tbx1 may suppress neural fate (Raft et al.,
2004) and may be important to establish the anterior–posterior
(A–P) axis of the otocyst. However, due to the apparent loss of
tissue and the highly abnormal morphology of the cranial
ganglia and nerves in Tbx1−/− embryos (Vitelli et al., 2002a,
2003), it is difficult to discern between a direct role of Tbx1 in
otocyst development and the consequences of extensive tissue
loss. Here we have used novel genetic approaches, including
timed ablation and fate mapping, to circumvent these issues and
to establish the roles of Tbx1 in inner ear development. Results
indicate that Tbx1 identifies a cell population that forms most of
the otocyst, excluding the neurogenic and the endolymphatic
duct territories. Tbx1 is required for localization, expansion and
fate of this cell population, but it is not required to establish its
A–P identity. This Tbx1-dependent cell population does not
normally contribute substantially to the cochleo-vestibular
ganglion, but timed deletion of Tbx1 results in the expansion
of the Delta-like1–Notch1 activation domain, and in change of
fate of at least some of the Tbx1-traced cells towards a
neurogenic fate. Finally, we demonstrate that both epithelial and
mesodermal expression of Tbx1 are essential for inner ear
development.Methods
Mouse mutants
All the experiments involving mice were done according to a protocol
reviewed and approved by the Institutional Animal Care and Use Committee of
Baylor College of Medicine, in compliance with the USA Public Health Service
Policy on Humane Care and Use of Laboratory Animals.
The following mouse mutant lines have been described previously:
TgCAGG-CreERTM (Hayashi and McMahon, 2002), Tbx1flox/flox, Tbx1ΔE5/+
and Tbx1mcm/+ (Xu et al., 2004, 2005), Tbx1+/lacZ (Lindsay et al., 2001), R26R
(Soriano, 1999) and TgFgf15Cre (Zhang et al., 2005). All lines were
backcrossed into the C57Bl6 genetic background for at least 2 generations.
Mice were genotyped using PCR as described in the original reports. To induce
nuclear translocation of the inducible Cre, including CreERTM and MerCreMer
encoded by the TgCAGG-CreERTM transgene and the Tbx1mcm allele,
respectively, pregnant mice were treated with single intraperitoneal injection
of Tamoxifen (Sigma) at a dose of 75 mg/kg body weight on embryonic day (E)
8.5. Tamoxifen was prepared as described before (Xu et al., 2005).
Histology, X-gal staining and immunohistochemistry
To visualize β-gal activity, we stained paraformaldehyde-fixed embryos
using the X-gal substrate, according to standard procedures. To clear embryos,they were fixed and dehydrated in ethanol:water:acetic acid:chloroform
(95:3:1:1) solution and then treated with methyl salicylate:benzyl benzoate
(50:50) solution. Stained embryos were photographed as whole mounts and then
embedded in paraffin and cut in 10 μm histological sections. Sections were
counterstained with Nuclear Fast Red. To visualize cartilage primordium of
temporal bone in E18.5 fetuses, paraffin sections were stained with Alcian blue
(pH 3.2) and counterstained with Alizarin red (pH 4.2). Three-dimensional
reconstruction was performed with WinSURF software. Immunohistochemistry
on paraffin sections was performed following the protocols accompanying the
antibodies or as described before (Xu et al., 2004, 2005). The following
antibodies were used for immunohistochemistry: rabbit anti-phospho-Histone
H3 (Ser10) (Upstate Biotechnology, 1:100), mouse anti-Tubulin-beta III, clone
TU-20 (Chemicon International, 1:200), mouse anti-Islet1, clone 2D6 and
mouse anti-neurofilament, clone 2H3 (Developmental Studies Hybridoma
Bank, 1:100), rabbit anti-cleaved Notch1 (Val1744) (Cell Signaling Technology,
1:100), rabbit anti-Tbx1 (Zymed) and rabbit anti-cleaved caspase 3 (Cell
Signaling Technology).
RNA in situ hybridization
RNA in situ hybridization experiments with radioactive probes were
performed on tissue sections according to published protocols (Albrecht et al.,
1997). Labeled probes (sense and antisense) were prepared by reverse
transcription of DNA clones in the presence of 35S-UTP (ICN). Probes used
in this study include: Ngn1 and Otx2 (obtained from Dr. Antonio Simeone),
Dlx5 (Depew et al., 1999) and Wnt2b (Ng et al., 2002) (obtained from
Dr. Daniel Choo), Bmp4 (obtained from Dr. James F. Martin) and Dll1
(obtained from Dr. Achim Gossler).Results
Tbx1 identifies and regulates the expansion of an otic epithelial
cell population that contributes to most of the otocyst
Tbx1−/− embryos exhibit small otocysts that are depleted of
cells with activated Tbx1 gene, as evaluated by Tbx1lacZ
expression (Raft et al., 2004; Vitelli et al., 2003). Consistent
with this observation, Tbx1−/−::Tbx1+/+ chimeric embryos
showed normal otocyst growth and absence of Tbx1−/− cells
in the otic epithelium, suggesting that mutant cells are
disadvantaged when competing with wild type cells in
populating the otic epithelium (Vitelli et al., 2003). As the
identification of mutant cells was based on the transcriptional
activity of the Tbx1lacZ allele, we could not exclude that at least
part of the β-gal negativity could have been due to shut down of
the reporter allele. We have previously shown that the Tbx1
gene and the Tbx1lacZ allele are expressed in the surface
ectoderm (Zhang et al., 2005), which provides precursors to the
otic epithelium, in wild type and homozygous mutants.
Therefore, we reasoned that, using a Cre knocked into the
Tbx1 locus, in combination with the Cre reporter R26R
(Soriano, 1999), we could trace the fate of Tbx1-expressing
cells into the otocyst even if gene expression is shut down in the
otocyst. The Tbx1mcm allele is functionally null and carries a
tamoxifen-inducible Cre driven by the endogenous regulatory
elements of Tbx1 (Xu et al., 2004). We crossed Tbx1mcm/+;
R26R mice with Tbx1ΔE5/+ mice (the Tbx1ΔE5 allele is
functionally null (Xu et al., 2004)) and injected a single dose
of Tamoxifen (TM) into pregnant females at E8.5. Because the
half-life of TM is ∼12 h, only cells that express Cre within a
∼24-hour time window and their progeny (hereafter referred to
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et al., 2005). At this time interval, Tbx1 is expressed in the
surface ectoderm (E8.5 to E9.0 Fig. S1D) and later in the
lateral–ventral–posterior region of the otocyst (Figs. 1A, A′,
Figs. S1A, A′). Cell fate mapping revealed numerous blue cells
in a subset of the otic epithelium in Tbx1mcm/+; R26R embryosFig. 1. Tbx1 regulates cell contribution and proliferation in the otic epithelium cell-a
locus. (B, B′) Cell fate mapping in Tbx1 heterozygous background. (C, C′) Cell fate
X-gal stained embryos, panels A, B and C are lateral to panels A′, B′ and C′, respectiv
beta III. Note the strongly reduced contribution of Tbx1-traced cells (blue) to the otic
embryo (B, B′), especially in the medial part of the otocyst (C′, magnified in the inset
to a lesser extent, to the cochleo-vestibular ganglion (VIII) in Tbx1 heterozygous bac
cells to the ganglia is similar except for a reduced contribution to the VIII (C′). (D, D
tamoxifen (TM) at E8.5. panel D′ is a sagittal section of the X-gal stained embryo in p
and second pharyngeal arches. (E–F) Coronal sections of E10.5 embryos stained wit
phospho-H3 to identify mitotic cells (brown). Blue staining indicates Tbx1 expressi
percentage of double-positive cells (β-gal and phospho-H3) versus all blue cells in the
and values represent mitotic cells over the total cells counted. Values are means of 4 o
values were calculated using the Student's t test. Ot: otocyst. Scale bars: 100 μm (Cat E10.5 (Figs. 1B, B′). Tbx1-traced cells populated the otocyst
extensively, sparing only an anterior region abutting the VIII
ganglion (the neurogenic area), and a dorsal region that includes
the endolymphatic duct. Tbx1-traced cells were also present in
the VIII–X ganglia (discussed later) (Figs. 1B, B′). In contrast,
E10.5 Tbx1mcm/ΔE5; R26R embryos (Tbx1 null) exposed to TMutonomously. (A, A′) Tbx1 expression as indicated by lacZ knocked into Tbx1
mapping in Tbx1 homozygous background, E10.5 embryos. Sagittal sections of
ely. Differentiated neurons (brown) are labeled with an antibody against Tubulin-
epithelium of the homozygous mutant (C, C′), compared with the heterozygous
). Also note the robust contribution of Tbx1-traced cells to ganglia IX and X, and
kground (B′). In Tbx1 homozygous background, the contribution of Tbx1-traced
′) Cell fate mapping in an E10.5 TgCAGG-CreERTM; R26R embryo exposed to
anel A. The white arrowhead in panel D indicates the otocyst area. I, II: the first
h X-gal and then processed for immunohistochemistry with an antibody against
on as revealed by the lacZ knock-in alleles. (G) Mitotic index calculated as the
otocyst. Brain is used as a control tissue (as Tbx1 is not expressed in this tissue),
tocysts/brains for each genotype group, error bars indicate standard deviation. P
′), 200 μm (D, D′) and 50 μm (F).
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mostly located in a latero-ventral region (Figs. 1C, C′). Thus,
Tbx1-driven fate mapping identifies a cell population that
contributes to a large portion of the otic epithelium and that
depends on Tbx1 function for populating the otocyst. This
finding probably accounts for the small size of the mutant
otocyst (Raft et al., 2004; Vitelli et al., 2003). These results also
beg the question of whether the loss of expression of molecular
markers in the null otocyst (Raft et al., 2004; Vitelli et al., 2003)
is due to loss of the Tbx1-dependent cell population or to the
loss of transcriptional regulation by Tbx1 in otic epithelial cells.
To address this question, we performed time-controlled ablation
of Tbx1. We used a previously described system in which a
ubiquitously expressed, TM-inducible Cre transgenic line
TgCAGG-CreERTM (Hayashi and McMahon, 2002) is crossed
with a mouse line carrying Tbx1flox, a floxed allele of Tbx1 (Xu
et al., 2004). This system allows virtually complete recombina-
tion of the Tbx1 floxed allele within 24 h of TM injection (Xu et
al., 2005). TgCAGG-CreERTM-induced recombination is ubi-
quitous in the inner ear of E10.5 embryos exposed to TM
injection at E8.5 (Figs. 1D–D′), and, by immunohistochemistry,
no Tbx1 protein could be detected in the otic epithelium of these
embryos (Fig. 2B). Therefore, this ablation timing should
preserve Tbx1 function in the pre-otocyst phases of inner ear
development, but remove it from the time of otic pit closure. We
crossed TgCAGG-CreERTM; Tbx1+/lacZ males with Tbx1flox/floxFig. 2. Normal patterning in the otic epithelium in Tbx1 timed mutants. Sagittal sectio
shows very reduced or lack of Tbx1 protein in a timed mutant (B). The same res
hybridization with a Bmp4 (C–E) and an Otx2 (F–H) RNA probe, respectively. Whil
their expression in otocyst of the timed mutants (B and E) is mildly lower than tha
100 μm.females and injected a single dose of TM to the pregnant
females at E8.5. Embryos were harvested at E10.5 and X-gal
stained. In contrast to Tbx1−/− otocysts, blue cells were present
in the otocyst of most TgCAGG-CreERTM; Tbx1flox/lacZ
embryos (hereafter referred to as Tbx1 timed mutants), but
there were fewer compared to Tbx1flox/lacZ controls (Fig. 1F,
compare to panel E). Cell counts in the otocysts of 4 embryos
(two time-deleted and two controls) indicated that the number of
blue cells in timed mutants is 16% (±9%) of controls. We tested
the expression of Bmp4 and Otx2, two molecular markers that
are absent in Tbx1−/− otocysts (Figs. 2C, F) (Raft et al., 2004;
Vitelli et al., 2003). Results showed normal, or mildly reduced
expression of these markers in the otocysts of Tbx1 timed
mutants (Figs. 2B, E, compare to panels A, D). These results
indicate that Tbx1 is not required for the expression of Bmp4
and Otx2 in the otic epithelium, suggesting that the loss of these
two markers in the null otocyst is due to loss of cells that
normally express them.
Induction of Tbx1 deletion at E7.5, using the same system,
resulted in the recapitulation of the null phenotype and complete
loss of blue cells in the otic epithelium (Figs. S1B, B′).
Next, we asked whether Tbx1 is required for the expansion
of Tbx1-traced cells after the closure of the otic pit. To this end,
we evaluate the mitotic activity of Tbx1-traced cells in timed
mutants obtained as described above. We examined sections
stained with X-gal and immunostained with a phospho-H3ns of E10.5 embryos. (A–B) Immunohistochemistry with an anti-Tbx1 antibody
ult was obtained in three different embryos with this genotype. (C–H) In situ
e Bmp4 and Otx2 expression is not detectable in the Tbx1 null otocyst (C and F),
t in the Tbx1 heterozygous control embryos (A and D), respectively. Scale bar:
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cells in which the Tbx1 gene is transcriptionally active). The
mitotic index in timed mutants (n=4) was less than half of that
of controls (Figs. 1E–G) (P=0.004). We also evaluated the
proliferation activity of the entire otic epithelial population (β-
gal+ and β-gal− cells combined) but found no significant
difference between timed mutants and controls (not shown).
The latter result is consistent with our previously published data
showing no significant change in the overall proliferation
activity of the otic epithelium of Tbx1−/− otocysts (Vitelli et al.,
2003).
Thus, delayed ablation of Tbx1 rescues part of the Tbx1-
traced cell population lost in germ line mutants, but its mitotic
activity is reduced.
We tested whether reduced cell survival may contribute to
the growth failure of the otocyst in timed mutants. Using an anti
cleaved-caspase 3 antibody, we observed a small domain of
apoptotic cells in the ventral region of E10.5 control otocysts (in
average 48±9 cells) (Fig. S1G). This region was expanded in
timed mutants (97±9 cells) (Fig. S1H). Thus, although a
reduction of cell survival may contribute to the growth failure of
the mutant otocyst, the very limited extent of the apoptotic
domain suggests a minor role.
Tbx1 is required for the appropriate fate specification of
Tbx1-expressing otic epithelial cells
Fate mapping of Tbx1 expressing cells revealed, unexpect-
edly, labeling of ganglia IX (petrosal) and X (nodose) and, to a
lesser extent, ganglion VIII (CVG) in Tbx1mcm/+; R26R
embryos (Figs. 1B, B′). Tbx1 is not expressed in these ganglia
at this stage (E10.5) (Figs. 1A, A′), but at the stage of
Tamoxifen induction (E8.5), it is expressed in the surface
ectoderm (Zhang et al., 2005) (Fig. S1D) that provides
precursors to ganglia IX and X and to the otic placode.
Labeling of the CVG is presumably due to expression in otic
epithelial precursors destined to provide neuronal cells to this
ganglion. Ganglia VIII–X can also be stained by cell fate
mapping with the TgFgf15Cre driver that is specific for
pharyngeal ectoderm, endoderm and otic epithelium (Zhang
et al., 2005) (Figs. 4A, A′). Germ line loss of Tbx1 did notFig. 3. Altered neurogenesis and Dll1-Notch1 signaling in Tbx1 mutants. (A–B and B
cells in a Tbx1 heterozygous embryo (A) and a timed mutant (B and B′). Differenti
against Tubulin-beta III. The arrows indicate the border between Tbx1-negative and T
The boxed area (B, magnified in panel B′) includes the ectopic ganglion composed m
(C–E) Whole mount immunohistochemistry with an antibody against Neurofilament
dashed line) in the timed mutant (D) and the homozygous mutant (E), compared with
the timed mutant (D, arrowhead) and expanded and displaced VIII ganglion in the ho
ganglion VII, IX and X (E) in the homozygous mutant. (F–H) Immunohistochemi
embryos. Arrowheads indicate the ectopic ganglion in the timed mutant (G), a
Immunohistochemistry with an antibody against Isl1 on sagittal sections from E
delaminating neuroblasts in the timed mutant (J) and homozygous mutant (K), compa
RNA probe on sagittal sections from E10.5 embryos. Note the extended Ngn1 dom
homozygous mutant (N), compared with that in the control embryo (L). (O–Q) In situ
Note the extended area (between arrows) positive for Dll1 in timed (P) and
Immunohistochemistry with an antibody against cleaved (activated) Notch1 on sa
populated by cleaved Notch1 positive cells (brown) in timed (S) and homozygous mu
10 μm (B′), 200 μm (E), and 50 μm (K, Q, T).significantly change the contribution of Tbx1-traced cells to
ganglia IX and X (Fig. 1C′, compare with 1 B′), suggesting that
Tbx1 does not have a direct role in neurogenesis. In contrast, the
overall contribution of Tbx1-traced cells to the VIII ganglion of
Tbx1 null embryos was lower than that of Tbx1 heterozygous
embryos (Fig. 1C′, compare with B′), consistent with the much
reduced Tbx1-traced cell population in the mutant otocyst.
However, Tbx1 null embryos exhibit an expansion of the
Neurogenin 1 (Ngn1) expression domain as well as enlarged
and malpositioned CVG (Figs. 3E, N and Raft et al., 2004). To
understand whether the expansion of the neurogenic domain of
the mutant otocyst is a consequence of the loss of Tbx1 function
or the loss of the Tbx1-traced cell population, we examined
neurogenesis in Tbx1 timed mutants. Ablation of Tbx1 after
E8.5 allowed contribution of at least some Tbx1-traced cells to
the otic epithelium (Fig. 2C), and, in contrast to germ line null
mutants, did not result in fusion of the CVG with projections of
ganglia VII, IX or X (Figs. 3D and G, compare with panels E and
H). We traced the fate of Tbx1-expressing cells in E10–E10.5
Tbx1mcm/+; R26R and Tbx1mcm/flox; R26R embryos exposed to
TM at E8.5. In these embryos, blue, Tbx1-traced cells are also
expected to be null for Tbx1 because of the recombination of the
Tbx1flox allele. X-gal stained embryos were also stained by
Tubulin-beta III immunohistochemistry to identify neurons. In
Tbx1mcm/flox; R26R embryos, the Tbx1-traced cell population
and the CVG were positioned correctly (Figs. 3A–B). However,
we found an ectopic population of Tubulin-beta III-positive cells
located ventral to the otocyst that was mainly made of Tbx1-
traced cells (Figs. 3B, B′). This ectopic ganglion was also
observed in TgCAGG-CreERTM; Tbx1flox/lacZ timed mutants
immunostained for Neurofilament (Fig. 3D) and Tubulin-beta
III (Fig. 3G). Immunohistochemistry of timed mutant otocysts
with an Isl1 antibody, which identifies delaminating neuroblasts
(Radde-gallwitz et al., 2004; Raft et al., 2004), revealed
expansion of the Isl1-positive domain, which overlapped with
the region populated by Tbx1-traced cells (Fig. 3J, compare with
panel B). RNA in situ hybridization of Ngn1 in timed mutants
showed caudal extension of the expression domain, overlapping
with the Tbx1-traced cell population (Fig. 3M, compare with
panel B). Thus, the ectopic ganglion is most likely contributed
by otocyst-derived Tbx1-traced cells that underwent a fate′) Sagittal sections of E10.5 embryos showing fate mapping of Tbx1-expressing
ated neurons (brown) were labeled by immunohistochemistry with an antibody
bx1-positive regions in the Tbx1 heterozygous (A) and homozygous otocyst (B).
ostly of Tbx1-traced cells. VII and VIII: normal ganglia VII and VIII; Ot: otocyst.
in E10.0 (32 somites) embryos. Note the reduced size of the otocyst (outlined by
that in the control embryo (C). The arrowheads indicate the ectopic ganglion in
mozygous mutant (E, arrowhead). The VIII ganglion is fused with projections of
stry with an antibody against Tubulin-beta III on sagittal sections from E10.5
nd the malpositioned VIII ganglion in the homozygous mutant (H). (I–K)
10.5 embryos. Note the extended Isl1 domain (between arrows) containing
red with that in the control embryo (I). (L–N) In situ hybridization with an Ngn1
ain (red between arrows) in the otic epithelium of the timed mutant (M) and
hybridization with a Dll1 RNA probe on sagittal sections from E10.5 embryos.
homozygous mutants (Q), compared to the control embryo (O). (R–T)
gittal sections from E10.5 embryos. Note the extended area (between arrows)
tants (T), compared to the control embryo (R). Scale bars: 100 μm (B, H and N),
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in the otocyst of the timed mutants was comparable to that of
germ line null mutants (Figs. 3J and M, compare with panels Kand N). Overall, our data demonstrate that partial restoration of
the Tbx1-traced cell population in the otocyst of timed mutants
is not sufficient to reset or maintain the border between the
Fig. 5. Tbx1 is required in the otic epithelium, but not in the periotic mesenchyme to set the border between neurogenic and non-neurogenic regions. (A, E, I) Whole
mount immunohistochemistry of Neurofilament in E10.0 embryos. The otocyst (outlined with dashed line) is smaller in the TgFgf15Cre; Tbx1flox/lacZ mutant (E), but
not in the Mesp1Cre/+; Tbx1flxo/lacZ mutant (I), compared with the control embryo (A). Note the ectopic ganglion in the TgFgf15Cre; Tbx1flox/lacZ mutant (E,
arrowhead). (B, F, J) Immunohistochemistry of Tubulin-beta III in sagittal sections of E10.5 embryos. Note the ectopic ganglion in the TgFgf15Cre; Tbx1flox/lacZ
mutant (F, arrowhead). (C, G, K) Immunohistochemistry of Isl1 in sagittal sections of E10.5 embryos. Note the extended area (between arrows) of the Isl1 domain
(brown) in the TgFgf15Cre; Tbx1flox/lacZ mutant (G), compared with the control embryo (C). The ectopic ganglion is indicated by the arrowhead (G). (D, H, L) RNA in
situ hybridization with Ngn1 on sagittal sections of E10.5 embryos. The TgFgf15Cre; Tbx1flox/lacZ mutant presents with an extended Ngn1 domain (red between
arrows, H), compared with the control embryo (D). Scale bars: 200 μm (I), 100 μm (J and L), 50 μm (K).
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Hence, cells expressing functional Tbx1 are required to set or
maintain this border.
To investigate whether Tbx1 is also involved in delimiting
the dorsal region of the otocyst destined to become theFig. 4. Distinct functions of Tbx1 expressed in the otic epithelium and the periotic
Panel A′ is a sagittal section of the embryo shown in panel A. Blue cells are found
mesenchyme. (B) Fate mapping of TgFgf15Cre-expressing cells at E12.5. TgFgf15C
Fate mapping of TgFgf15Cre-expressing cells in conditional mutants. Panel C′ is
(arrows). (D) Fate mapping of TgFgf15Cre-expressing cells in a Tbx1 conditiona
endolymphatic duct (ed) is well formed. (E, E′) Fate mapping of Mesp1Cre-expressin
Blue cells are found in periotic mesenchyme (asterisk), but not in the otic epitheli
otocyst at E10.5. Panel F′ is a sagittal section of the embryo shown in panel F. T
endolymphatic duct and the otic epithelial patch abutting the VIII ganglion (neuroge
Distribution of Tbx1-expressing cells in the inner ear at E12.5. Tbx1-expressing c
Distribution of Tbx1-expressing cells in the otocyst of a TgFgf15Cre; Tbx1flox/lacZ m
There is a reduced contribution of Tbx1-expressing cells to the otocyst (arrowheads
Tbx1flox/lacZ mutant. (J, J′) Normal otocyst and pattern of Tbx1-expressing cells in th
cochlea in a Mesp1Cre/+; Tbx1flox/lacZ mutant at E12.5. asc: anterior semicircular cana
and utricle; Co: cochlea; ed: endolymphatic duct. Scale bars: 200 μm (J and K) anendolymphatic duct, we performed RNA in situ hybridization
with probes for Dlx5 and Wnt2b, both of which identify this
region (Choo et al., 2006). Results showed no significant
difference between Tbx1 deficient embryos (timed mutants and
germ line null mutants) and Tbx1+/− controls (Figs. S2A–F).mesenchyme. (A, A′) Fate mapping of TgFgf15Cre-expressing cells at E10.5.
in the otic epithelium as well as in the VII–X ganglia, but not in the periotic
re-traced cells contribute to all the primitive structures of the inner ear. (C, C′)
a sagittal section of the embryo shown in panel C. Note the ectopic ganglion
l mutant at E12.5. Note the severe defects of the sensory organs while the
g cells at E10.5. Panel E′ is a sagittal section of the embryo shown in panel E.
um. (F, F′) Distribution of Tbx1-expressing cells (blue) in Tbx1 heterozygous
bx1-expressing cells populate most of the otocyst (arrowheads) except for the
nic region). Also notice the blue cells in the periotic mesenchyme (asterisk). (G)
ells populate the sensory structures, but not the endolymphatic duct. (H, H′)
utant at E10.5. Panel H′ is a sagittal section of the embryo shown in panel G.
). (I) Severe morphological defects of the inner ear at E12.5 in a TgFgf15Cre;
e otocyst of a Mesp1Cre/+; Tbx1flox/lacZ mutant at E10.5. (K) Malformation of the
l; psc: posterior semicircular canal; lsc: lateral semicircular canal; S+U: saccule
d 100 μm (J′).
678 H. Xu et al. / Developmental Biology 302 (2007) 670–682These results suggest that the main patterning function of Tbx1
in early inner ear development is to set or maintain a ventro-
posterior boundary to the neurogenic region of the otocyst.
Loss of Tbx1 is associated with expansion of Delta–Notch1
activation
The Delta–Notch signaling pathway has been proposed to
select neuronal fate of a subpopulation of epidermal cells early
during the formation of the cranial ganglia (Austin et al., 1995;
Chitnis et al., 1995; De la Pompa et al., 1997; Nye et al., 1994).
We asked whether this pathway might also be activated at the
border between the neurogenic and non-neurogenic regions of
the otocyst. By RNA in situ hybridization, we could
demonstrate the expression of Delta-like 1 (Dll1), and, by
immunohistochemistry, the presence of the cleaved (activated)
form of Notch1 (aNotch1) in a restricted domain of the otic
epithelium adjacent to the CVG of control E10.5 embryos
(Figs. 3O, R), that was mostly overlapping with the Ngn1
expression domain (Fig. 3L). The Dll1–aNotch1 domain also
appeared to be partially overlapping with or adjacent to theFig. 6. Tbx1 expression in the mesoderm is required for cochlear morphogenesis. (A
E12.5. Dorsal view of cleared embryos after X-gal staining. The cochlea in the Me
Histological sections of specimens shown in panels A and B, respectively. Note the pr
embryo (red asterisk) and the loss of this cell population in the conditional mutant
identifies the cartilage (in blue). Note the severely hypoplastic cochlea in theMesp1C
panel C′ shows a detail of the organ of Corti (OC) in the control specimen; no such
lesser epithelial ridge; GER: greater epithelial ridge; SC: semicircular canal; SG: spTbx1-expressing area (Fig. S3). Thus, Dll1–Notch1 signaling
may play a role in delimiting the ventral–posterior neurogenic
border of the otocyst. As this border is profoundly affected by
loss of function of Tbx1, we asked whether the Dll1–aNotch1
domain could be altered. Indeed, we found considerable expan-
sion of this domain in Tbx1 timed or germ line mutants, simi-
larly to the Isl1- and Ngn1-positive domains (Figs. 3P, Q, S, T).
These results suggest that Delta–Notch signaling is affected,
directly or indirectly, by Tbx1 mutation.
Both epithelial and mesodermal expression of Tbx1 are
required for inner ear development
During inner ear morphogenesis, Tbx1 is expressed both in
the periotic mesenchyme and the otic epithelium, both tissues
are known to be required for inner ear development (Barald and
Kelley, 2004; Noramly and Grainger, 2002). To establish which
of these two expression domains is critical for the develop-
mental roles described above, we performed tissue-specific
ablation of Tbx1 in the otic epithelium and in the mesoderm. To
this end, we used a TgFgf15Cre transgenic line (Zhang et al.,, B) Pattern of Tbx1 expression in the cochlea and surrounding mesenchyme at
sp1Cre/+; Tbx1flox/lacZ mutant appears shorter (between white arrows). (A′–B′)
esence of a β-gal+ cell population of the periotic mesenchyme in the Tbx1flox/lacZ
. (C, D) Transverse sections of E18.5 fetuses after Alcian blue staining, which
re/+; Tbx1flox/lacZ fetus as reconstructed in the 3-dimensional models (C″ and D″).
structures could be identified in the conditional mutant (D′). Co: cochlea; LER:
iral ganglion; SM: scala media; ST: scala tympani; SV: scala vestibuli.
679H. Xu et al. / Developmental Biology 302 (2007) 670–6822005) that induces recombination in pharyngeal ectoderm,
endoderm and in the otic epithelium (Figs. 4A, A′), and the
knock-in line Mesp1Cre/+ (Saga et al., 1999; Zhang et al., 2006)
that induces recombination in the mesoderm but not in epithelia
(Figs. 4E, E′). Ablation of Tbx1 by TgFgf15Cre resulted in a
small otocyst (Figs. 4C, C′, compare with A, A′), an ectopic
ganglion at E10.5 (Figs. 4C, C′, 5E, compare with Figs. 4A, A′,
5A) and dysplasia of otocyst derivatives at E12.5 (Fig. 4D). X-gal
staining of TgFgf15Cre; Tbx1flox/lacZ embryos, identifying
Tbx1-expressing cells, revealed the presence of a small popula-
tion ofβ-gal-positive cells in the otocyst (Figs. 4H, H′, compared
with panels F, F′). This population was variable in extent,
probably due to slight variability in the onset of Cre-mediated
recombination, which starts at approximately E9.0 (Zhang et al.,
2005). Consistent with this time of onset, the otic phenotype of
embryos was similar to that of Tbx1 timed mutants, in which the
ablation is also predicted to occur at around E9 following TM
induction at E8.5. In TgFgf15Cre; Tbx1flox/lacZ mutants, the size
of the otocyst (Fig. 5E, compare with Fig. 3D), the pattern of
neurogenesis, as evaluated by immunohistochemistry of Neuro-
filament (Fig. 5E, compare with Fig. 3D), Tubulin-beta III (Fig.
5F, compare with Fig. 3G) and Isl1 (Fig. 5G, compare with Fig.
3J) and by RNA in situ ofNgn1 (Fig. 5H, compare with Fig. 3M),
and the pattern of aNotch1 (data not shown) were indistinguish-
able. These results indicate that Tbx1 expression in the otic
epithelium is required for morphogenesis and regional specifica-
tion of the otocyst. These results are also consistent with data
recently reported obtained with an independent Cre line (Arnold
et al., 2006). In contrast,Mesp1Cre-induced deletion of Tbx1 did
not cause any apparent abnormalities to the otocyst, as tested at
E10.5 with β-gal expression (Figs. 4J, J′), immunostaining of
Neurofilament (Fig. 5I), Tubulin-beta III (Fig. 5J) and Isl1
(Fig. 5K) and RNA in situ hybridization of Ngn1 (Fig. 5L).
However, inner ear abnormalities in Mesp1Cre/+; Tbx1flox/−
embryos become evident from E12.5. X-gal staining revealed
that the cochlear duct is shorter in the tissue-specific Tbx1
mutants (Fig. 6B) compared to control embryos (Fig. 6A),
suggesting impaired cochlear development. Histological sec-
tions of X-gal-stained Tbx1flox/lacZ; Mesp1Cre/+ embryos at
E12.5 revealed a normal morphology of the inner ear (but with
a shorter cochlear duct), with normal distribution of β-gal+ cells
(Figs. 5K, 6B, B′). However, the periotic mesenchyme had very
few β-gal+ cells at this stage (Fig. 6B′, asterisk). This finding is
consistent with our recently published data showing a cell-
autonomous proliferation defect in the mesoderm of early (E8.5)
Mesp1Cre/+; Tbx1flox/− embryos (Zhang et al., 2006). At E18.5,
the cochlea is hypoplastic, as illustrated by 3-dimensional
reconstruction of the scala media, the mutant cochlea appeared
short and failed to turn, resulting in a primitive structure
reminiscent of a distorted “L” (Fig. 6D″). Examination of
histological sections did not reveal any morphologically
recognizable organ of Corti (Figs. 6D, D′, compare to panels
C, C′). These results suggest that there are Tbx1-dependent,
mesodermally derived signals required for “late” cochlear
development. These signals may be directly regulated by Tbx1
or may be generated by mesodermal cells, the presence of which
is dependent upon Tbx1 function.Discussion
Tbx1 regulates the size of the otocyst by controlling
contribution and proliferation of a large population of cells in
the otic epithelium
Tbx1 is expressed broadly in the inner ear starting from the
otic pit stage, and possibly also in ectodermal precursors of otic
epithelial cells. The domain is initially localized to the
posterior–lateral region, but from ∼E9.0, it extends rapidly to
include most of the otocyst, excluding only the endolymphatic
duct and a region abutting the CVG ganglion. Cells expressing
Tbx1 contribute to the cochlea and vestibular system, thus
encompassing most of the inner ear. We have demonstrated that
Tbx1 is required for the contribution of a large population of
cells to the otocyst. Delayed ablation of Tbx1 partially rescued
this cell population, but strongly reduced its proliferation in the
otocyst. These findings probably explain the profound mor-
phogenetic defects caused by germ line or timed deletion of
Tbx1. A proliferation defect is likely to be the cause of the
loss, or strong reduction, of Tbx1-traced cells in the null
otocyst, but we cannot exclude that Tbx1 has an additional role
in allocating ectodermal precursors to the otic epithelium.
We have previously shown that Tbx1 regulates cell
proliferation in other tissues (Xu et al., 2004, 2005), but the
underlying mechanisms are unclear. One possibility is that this
effect is mediated by regulation of genes encoding growth
factors such as the fibroblast growth factors (FGF) (Hu et al.,
2004; Vitelli et al., 2002b; Xu et al., 2004).
The loss of a large cell population of the Tbx1 null otocyst
explains why a number of molecular markers located in the
posterior region, like Bmp4 and Otx2 tested here, (Raft et al.,
2004; Vitelli et al., 2003) are absent. The loss of those markers
suggested an anteriorization of the mutant otocyst and led to the
hypothesis that Tbx1 is a determinant of the A–P axis and a
positive regulator of Bmp4 expression (Raft et al., 2004). Here
we show that the loss of the posterior markers Bmp4 and Otx2
in the null otocyst is due to loss of tissue rather than to
transcriptional control or anteriorization of the mutant otocyst.
Tbx1 is required to delimit the neurogenic domain in the
otocyst
We have addressed the role of Tbx1 in neurogenesis in vivo
using conditional and knock-in alleles. Unexpectedly, fate
mapping of Tbx1-expressing cells revealed that the gene is
expressed in precursors of neural cells of cranial ganglia VIII–
X, albeit the contribution of Tbx1-traced cells to the CVG (VIII)
was relatively small. Cell fate mapping on a null background did
not reveal significant changes in contribution to ganglia IX and
X, indicating that, in general, expression of Tbx1 in neuronal
precursors is not required for and does not suppress neuronal
specification. In the CVG, however, there were fewer Tbx1-
traced cells in null mutants. Because the CVG precursors derive
from the otic epithelium, the observation is consistent with the
finding that the gene is required for cell contribution to the
otocyst. Nevertheless, the neurogenic gene expression program
680 H. Xu et al. / Developmental Biology 302 (2007) 670–682in the otocyst of Tbx1−/− embryos was expanded, and the CVG
malpositioned, misshaped, and possibly enlarged. Evidently, the
neurogenic expansion is not due to a cell-autonomous fate
determination function of Tbx1 and we asked whether it could
be secondary to the loss of the large, Tbx1-traced cell
population. Partial rescue of cell contribution using timed
mutants normalized the positioning and, at least in part, the
morphology of the CVG. The rescued cell population localized
correctly to the region of the otocyst where cells expressing
functional Tbx1 normally localize, i.e. forming a sharp border
with the neurogenic region ventro-anteriorly. However, this was
not sufficient to correct the neurogenic expression program as
Ngn1 and Isl1 expression was expanded and extended into the
adjacent Tbx1-traced cell population. Consistent with these
data, we demonstrated that a subpopulation of Tbx1-traced cells
took on a neurogenic fate and contributed to an ectopic
ganglion-like structure located ventro-posteriorly to the CVG.
Overall, these data conclusively demonstrate that it is Tbx1
expression, and not the missing cell population, that delimits the
neurogenic region in the otocyst. In the absence of cells actively
expressing Tbx1, the border is set more ventro-posteriorly,
adjacent to the endolymphatic duct region as identified by Dlx5Fig. 7. Schematic summary of Tbx1 roles during early inner ear development. (A) In
Tbx1 coding sequence by the knock-in of the inducible Cre, mcm), Tbx1-traced cells
(white) and the endolymphatic area (brown). There is also modest contribution of Tb
applied to pregnant females at E8.5. (A′) Tbx1 expression in the otic epithelium prom
the expression of Ngn1. Ngn1 expressed in neuronal precursors activates neurogenes
receptors on neighboring cells (as indicated by “||”). It has been proposed that the activ
expressed in Tbx1-expressing cells (as indicated by an “X” on “Ngn1”). Note that the
neurogenic and Tbx1-expressing domains (*). (B1–B2) In Tbx1-deficient embryos (B
neurogenesis is expanded. When the mutation is timed (panel B1, genotype: Tbx1
m
persist in the otic epithelium and there is an ectopic ganglion primarily composed of T
Tbx1mcm/ΔE5; R26R, exposed to TM at E8.5), very few Tbx1-traced cells remain in th
(B′) Tbx1 loss of function (as indicated by an “X” on “Tbx1”) in the otic epithelium fa
“X”), which results in reduced population of Tbx1-traced cells in the otic epithelium,
that ectopic Ngn1, in turn, promotes ectopic neurogenesis, Dll1 expression and actiand Wnt2b expression. Our data also indicate that the Tbx1-
traced population, although destined to a specific region of the
otocyst, is not committed to differentiate into a particular cell
type, but it can change its fate depending on the local gene
expression program in the otocyst. In addition, our tissue-
specific ablation experiments demonstrated that the delimitation
of the neurogenic region by Tbx1 is epithelial-autonomous.
Finally, our time-controlled deletion experiments suggest that
the border can be set (or reset) as late as E8.5–E9.0.
The molecular mechanisms that set the border of the
neurogenic region in the otocyst are unknown. Delta–Notch
signaling plays a role in determining the neurogenic versus non-
neurogenic fate in other tissue contexts (Lai, 2004). Delta is
positively regulated by proneural genes Ngn1 and NeuroD (Ma
et al., 1998). In turn, Delta activates Notch in neighboring cells,
and aNotch suppresses proneural gene expression in those cells.
Here we showed that expression of Dll1, a Notch ligand, and
the cleaved form of Notch1, is found at or near the neurogenic
border region, suggesting that the Delta–Notch signaling could
play a role in setting or maintaining the border. Tbx1 mutation
is associated with a considerable expansion of the Dll1–
aNotch domain, suggesting that it functions upstream of aTbx1mcm/+; R26R embryos (heterozygous for Tbx1 null due to the disruption of
(blue) contribute extensively to the otocyst (Ot) except for the neurogenic area
x1-traced cells to the cochleo-vestibular ganglion (CVG). Tamoxifen (TM) was
otes the proliferation of otic epithelial cells and suppresses (directly or indirectly)
is and perhaps also the expression of Dll1, which binds to and activates Notch1
ated Notch1 pathway can inhibit Ngn1 expression (Ma et al., 1998). Ngn1 is not
model of Tbx1 role in neurogenesis only applies to cells bordering between the
1 and B2), contribution of Tbx1-traced cells to the otocyst (Ot) is impaired, and
cm/flox; R26R, exposed to TM at E8.5), a small population of Tbx1-traced cells
bx1-traced cells. When the mutation is null in the germ line (panel B2, genotype:
e otic epithelium, and the CVG is expanded, containing some Tbx1-traced cells.
ils to promote cell proliferation or suppress Ngn1 expression (as indicated by the
and ectopic expression of Ngn1 (as indicated by “Ngn1” in green). We speculate
vation of Notch1 (green).
681H. Xu et al. / Developmental Biology 302 (2007) 670–682possible Notch-mediated mechanism for selecting cells under-
going neurogenic fate. Tbx1 may suppress Ngn1 and/or Dll1
expression.
In summary, we have provided evidence that Tbx1
identifies and regulates an otic epithelial cell population that
forms most of the developing inner ear (Fig. 7). Within this
cell population, Tbx1 (A) regulates cell contribution to the
otocyst, (B) maintains proliferation and (C) maintains a non-
neurogenic fate. The first two roles are probably the
expression of the same pro-proliferative effect of Tbx1 that
has been demonstrated in other developmental processes. The
third role may be effected by suppressing Ngn1 and/or Dll1
expression.
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